Cargando…

Methylation profile of triple-negative breast carcinomas

Breast cancer is a group of clinically, histopathologically and molecularly heterogeneous diseases, with different outcomes and responses to treatment. Triple-negative (TN) breast cancers are defined as tumors that lack the expression of estrogen receptor, progesterone receptor and epidermal growth...

Descripción completa

Detalles Bibliográficos
Autores principales:	Branham, M T, Marzese, D M, Laurito, S R, Gago, F E, Orozco, J I, Tello, O M, Vargas-Roig, L M, Roqué, M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2012
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3412652/ https://www.ncbi.nlm.nih.gov/pubmed/23552734 http://dx.doi.org/10.1038/oncsis.2012.17

Ejemplares similares

Aberrant DNA methylation of cancer-related genes in giant breast fibroadenoma: a case report
por: Marzese, Diego M, et al.
Publicado: (2011)

Intratumor heterogeneity index of breast carcinomas based on DNA methylation profiles
por: Campoy, Emanuel M., et al.
Publicado: (2019)

Asymmetric Cancer Hallmarks in Breast Tumors on Different Sides of the Body
por: Campoy, Emanuel M., et al.
Publicado: (2016)

Epigenetic regulation of ID4 in breast cancer: tumor suppressor or oncogene?
por: Nasif, Daniela, et al.
Publicado: (2018)

Epigenetic Regulation of Immunotherapy Response in Triple-Negative Breast Cancer
por: Llinàs-Arias, Pere, et al.
Publicado: (2021)

Current Triple-Negative Breast Cancer Subtypes: Dissecting the Most Aggressive Form of Breast Cancer
por: Ensenyat-Mendez, Miquel, et al.
Publicado: (2021)

Epigenetic Profiles of Triple-Negative Breast Cancers of African American and White Females
por: Ensenyat-Mendez, Miquel, et al.
Publicado: (2023)

PAX6 Promoter Methylation Correlates with MDA-MB-231 Cell Migration, and Expression of MMP2 and MMP9
por: Urrutia, Guillermo, et al.
Publicado: (2018)

3-D chromatin conformation, accessibility, and gene expression profiling of triple-negative breast cancer
por: Llinàs-Arias, Pere, et al.
Publicado: (2023)

Working together for the family: determination of HER oncogene co-amplifications in breast cancer
por: Laurito, Sergio, et al.
Publicado: (2020)

Genome-wide chromatin accessibility, DNA methylation and gene expression analysis of histone deacetylase inhibition in triple-negative breast cancer
por: Bustos, Matias A., et al.
Publicado: (2017)

Construction and validation of a gene expression classifier to predict immunotherapy response in primary triple-negative breast cancer
por: Ensenyat-Mendez, Miquel, et al.
Publicado: (2023)

Epigenetic and transcriptional profiling of triple negative breast cancer
por: Perreault, Andrea A., et al.
Publicado: (2019)

Functional Proteomic Profiling of Triple-Negative Breast Cancer
por: Gromova, Irina, et al.
Publicado: (2021)

When left does not seem right: epigenetic and bioelectric differences between left- and right-sided breast cancer
por: Masuelli, Sofía, et al.
Publicado: (2022)

Correction to: When left does not seem right: epigenetic and bioelectric differences between left and right‑sided breast cancer
por: Masuelli, Sofia, et al.
Publicado: (2022)

Targeting DNA methylation for treating triple-negative breast cancer
por: Yu, Jia, et al.
Publicado: (2019)

Gene expression profiling and histopathological characterization of triple-negative/basal-like breast carcinomas
por: Kreike, Bas, et al.
Publicado: (2007)

Genomic characteristics of triple negative apocrine carcinoma: a comparison to triple negative breast cancer
por: Kim, Ji-Yeon, et al.
Publicado: (2023)

Kinome profiling reveals breast cancer heterogeneity and identifies targeted therapeutic opportunities for triple negative breast cancer
por: Al-Ejeh, Fares, et al.
Publicado: (2014)

DNA Methylation and Prospects for Predicting the Therapeutic Effect of Neoadjuvant Chemotherapy for Triple-Negative and Luminal B Breast Cancer
por: Sigin, Vladimir O., et al.
Publicado: (2023)

DNA methylation markers predict recurrence-free interval in triple-negative breast cancer
por: Fackler, Mary Jo, et al.
Publicado: (2020)

Triple negative breast carcinoma EGFR amplification is not associated with EGFR, Kras or ALK mutations
por: Secq, V, et al.
Publicado: (2014)

Classification of triple-negative breast cancers based on Immunogenomic profiling
por: He, Yin, et al.
Publicado: (2018)

Immunotherapy for the Treatment of Triple-Negative Breast Cancer
por: Tolaney, Sara M., et al.
Publicado: (2022)

Molecular Characteristics and Metastasis Predictor Genes of Triple-Negative Breast Cancer: A Clinical Study of Triple-Negative Breast Carcinomas
por: Kuo, Wen-Hung, et al.
Publicado: (2012)

Milking the stroma in triple-negative breast cancer
por: Thompson, Alastair M., et al.
Publicado: (2012)

Depletion of Mdig Changes Proteomic Profiling in Triple Negative Breast Cancer Cells
por: Thakur, Chitra, et al.
Publicado: (2022)

Molecular Features of Metaplastic Breast Carcinoma: An Infrequent Subtype of Triple Negative Breast Carcinoma
por: González-Martínez, Silvia, et al.
Publicado: (2020)

MGMT promoter methylation in triple negative breast cancer of the GeparSixto trial
por: Jank, Paul, et al.
Publicado: (2020)

A DNA methylation-based liquid biopsy for triple-negative breast cancer
por: Cristall, Katrina, et al.
Publicado: (2021)

DNA methylation profile of triple negative breast cancer-specific genes comparing lymph node positive patients to lymph node negative patients
por: Mathe, Andrea, et al.
Publicado: (2016)

Overview of recent advances in metastatic triple negative breast cancer
por: O'Reilly, David, et al.
Publicado: (2021)

Differential cytotoxic and radiosensitizing effects of silver nanoparticles on triple-negative breast cancer and non-triple-negative breast cells
por: Swanner, Jessica, et al.
Publicado: (2015)

Subtyping Of Triple Negative Breast Carcinoma On The Basis Of RTK Expression
por: Hessel, Harald, et al.
Publicado: (2018)

Expression of SOX10 in Triple-Negative Breast Carcinoma in Pakistan
por: Ali, Seemal, et al.
Publicado: (2022)

Triple Negative Breast Cancer Profile, from Gene to microRNA, in Relation to Ethnicity
por: Gupta, Ishita, et al.
Publicado: (2019)

Wnt signaling in triple-negative breast cancer
por: Pohl, SÖ-G, et al.
Publicado: (2017)

Impact of TP53 mutations in Triple Negative Breast Cancer
por: Mitri, Zahi I., et al.
Publicado: (2022)

Triple‐negative breast carcinomas are a heterogeneous entity that differs between young and old patients
por: Carvalho, Filomena M, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_vs1ju1l5jqdb46gr8acuau1jcj